---
figid: PMC8042267__fimmu-12-622934-g004
figtitle: Therapeutic approaches targeting IL23 and IL17 signaling
organisms:
- NA
pmcid: PMC8042267
filename: fimmu-12-622934-g004.jpg
figlink: pmc/articles/PMC8042267/figure/f4/
number: F4
caption: Therapeutic approaches targeting IL23 and IL17 signaling. Ustekinumab and
  briakinumab specifically blocks the IL12/IL23 subunit p40 in CD patients whereas
  risankizumab, brazikumab, guselkumab and mirikizumab selectively block the unique
  subunit p19. Activated Th17 cells produce large amounts of IL17. Secukinumab directly
  binds to IL17A and thereby inhibits the interaction with the IL17 receptor (IL17R).
  Brodalumab directly binds to the IL17R causing an inhibition of IL17 ligand binding
  (A and F) to their receptor.
papertitle: Role of the IL23/IL17 Pathway in Crohnâ€™s Disease.
reftext: Heike Schmitt, et al. Front Immunol. 2021;12:622934.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9504447
figid_alias: PMC8042267__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8042267__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8042267__fimmu-12-622934-g004.html
  '@type': Dataset
  description: Therapeutic approaches targeting IL23 and IL17 signaling. Ustekinumab
    and briakinumab specifically blocks the IL12/IL23 subunit p40 in CD patients whereas
    risankizumab, brazikumab, guselkumab and mirikizumab selectively block the unique
    subunit p19. Activated Th17 cells produce large amounts of IL17. Secukinumab directly
    binds to IL17A and thereby inhibits the interaction with the IL17 receptor (IL17R).
    Brodalumab directly binds to the IL17R causing an inhibition of IL17 ligand binding
    (A and F) to their receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL37
  - IL23A
  - IL12B
  - IL12A
  - CDKN2A
  - CDKN2D
  - F9
  - REG1A
  - H3P13
  - IL9
  - RPSA
  - MAPK1
  - PSMD7
  - TP63
  - ARHGEF2
  - RABEPK
  - LANCL1
  - EBNA1BP2
  - BRMS1L
  - ARMH1
  - H3P28
  - NELFCD
  - IL17F
  - IL17A
  - IL17RA
  - IL23R
  - IL12RB1
  - IL12RB2
---
